Pulmonary embolism: update on management and controversies

Area of Science:

• Cardiovascular Medicine
• Pulmonology
• Hematology

Background:

• Pulmonary embolism (PE) is a critical cardiovascular condition requiring timely diagnosis and management.
• Advances in understanding diagnostic and therapeutic options have refined PE care.
• Current strategies aim to improve diagnostic accuracy and patient outcomes.

Purpose of the Study:

• To review the evolving landscape of pulmonary embolism diagnosis and management.
• To highlight the role of updated diagnostic tools and novel therapeutic strategies.
• To discuss risk stratification for recurrent events and long-term management.

Main Methods:

• Review of recent clinical trials and guidelines on pulmonary embolism.
• Analysis of diagnostic approaches including D-dimer testing and imaging.
• Evaluation of anticoagulation therapies, thrombolysis, and risk prediction scores.

Main Results:

• Clinical probability-adjusted or age-adjusted D-dimer interpretation reduces unnecessary imaging.
• Direct oral anticoagulants offer safe and effective treatment, facilitating outpatient management.
• Systemic thrombolysis is reserved for hemodynamically compromised patients; its role in others is uncertain.
• Risk assessment guides anticoagulation duration, with extended therapy for high-risk or unprovoked events.

Conclusions:

• Modern management of pulmonary embolism emphasizes efficient diagnosis and tailored, safe treatment.
• Direct oral anticoagulants have improved patient convenience and outpatient care options.
• Risk stratification is crucial for determining optimal anticoagulation duration to prevent recurrence.
• Chronic functional limitations post-PE warrant further investigation and management strategies.